Marstacimab API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Marstacimab API is a high-quality biopharmaceutical active ingredient classified as a tissue factor pathway inhibitor (TFPI) antagonist and human monoclonal immunoglobulin G1 antibody. Marstacimab is specifically directed against the Kunitz domain 2 of TFPI and is associated with hemostatic and hemophilia-related biopharmaceutical applications.

Marstacimab works by targeting TFPI, a natural anticoagulation protein involved in regulating the tissue factor pathway. By inhibiting TFPI activity, marstacimab supports thrombin generation and helps rebalance hemostasis. It is associated with pharmaceutical development and prophylactic treatment applications related to hemophilia A and hemophilia B.

Swapnroop Drugs and Pharmaceuticals is a trusted Marstacimab API manufacturer and bulk supplier in Maharashtra, India, offering reliable pharmaceutical and biopharmaceutical raw material supply solutions for domestic and international markets. We support biopharmaceutical companies, formulation developers, research organizations, and global buyers with quality-focused sourcing, technical documentation, and dependable supply services.

Our Marstacimab API supply is supported with applicable product specifications and quality documentation based on customer and manufacturing requirements. We focus on consistent quality, reliable supply, professional service, suitable biopharmaceutical packaging, and international pharmaceutical business support.

As a reliable Marstacimab API supplier in India, Swapnroop Drugs and Pharmaceuticals supports bulk requirements, biopharmaceutical development, analytical research, and export enquiries. Contact us for Marstacimab API price, bulk quantity requirements, specifications, COA, documentation, packaging details, and international supply requirements.

Applications

  • Used in hemophilia-related biopharmaceutical development
  • Used in tissue factor pathway inhibitor antagonist research
  • Applied in hemostatic pharmaceutical development
  • Used in monoclonal antibody research and development
  • Associated with hemophilia A and hemophilia B pharmaceutical applications
  • Used in biopharmaceutical and analytical research applications

Packaging

Marstacimab API is supplied in suitable validated biopharmaceutical-grade packaging systems designed to maintain product quality and stability. Packaging is selected according to product stability, temperature control, and customer requirements. Customized bulk and export packaging options are available according to supply requirements.

Storage

Store under recommended refrigerated or frozen conditions as specified by the manufacturer. Protect from light and avoid repeated freeze-thaw cycles. Maintain validated temperature-controlled storage and transportation conditions according to product stability and manufacturer specifications.

Get Bulk Quote via WhatsApp